Cover Stories

Cover Stories

An in-depth look at trends and controversies in hematology and oncology.

Cover Story

Sickle cell disease poised for ‘golden age of treatment’ amid progress toward cure

HemOnc Today, June 10, 2019
As researchers work to expand curable approaches for sickle cell disease, new options for managing its acute and chronic complications appear within…
Cover Story

‘A Moment of Marvel’ in Manhattan Brings a Revolution in CAR T-Cell Therapy

Cell Therapy Next, May 2019
When the first flow cytometry analysis was run after a CAR T-cell therapy, showing no evidence of leukemia, Michel Sadelain, MD, PhD, and Isabelle
Cover Story

Efforts to reduce racial disparities in cancer care aim to ‘make the invisible visible’

HemOnc Today, May 25, 2019
The trends are clear — not only do ethnic and racial minority groups face poorer cancer outcomes, they also are less frequently invited to…
Cover Story

Venous thromboembolism guidelines aim to clarify proper care in areas with ‘a lot of uncertainty’

HemOnc Today, May 10, 2019
Venous thromboembolism — which includes deep vein thrombosis and pulmonary embolism — causes up to 100,000 deaths annually in the United…
Cover Story

Telemedicine in oncology: Virtual solution to a very real problem

HemOnc Today, April 25, 2019
Following the lead of businesses, consumer transactions, news dissemination and more, medicine — a profession rooted in a…
Cover Story

Life at City of Hope: ‘It’s Always a Great Day to Cure Cancer.’

Cell Therapy Next, April 2019
Walking between the wishing trees as one enters City of Hope, it is easy to comprehend what patients and physicians alike mean when they describe the…
Cover Story

Advances in chronic lymphocytic leukemia suggest progress is ‘visible on the horizon’

HemOnc Today, April 10, 2019
The transition from primarily chemotherapy-based approaches to targeted therapies revolutionized treatment of chronic lymphocytic leukemia, the most…
Cover Story

New indications may accelerate ‘explosion’ in CAR T-cell therapy, but more education still needed

HemOnc Today, March 25, 2019
Years of research into chimeric antigen receptor T-cell therapy for cancer treatment is finally paying dividends. When Renier J. Brentjens, MD
Cover Story

‘There needs to be urgency’ to address late endocrinopathies in childhood cancer survivors

HemOnc Today, March 10, 2019
For pediatric cancer survivors, the disease and its treatments place them at risk for subsequent health complications, many of which are endocrine…
Cover Story

Targeted treatments for acute myeloid leukemia yield modest improvements, great hope

HemOnc Today, February 25, 2019
Acute myeloid leukemia historically has been one of the more deadly and difficult-to-treat cancers, with a 5-year survival rate below 30%. Moreover…